These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4959332)
1. Medical grand rounds from the University of Alabama Medical Center. South Med J; 1966 Nov; 59(11):1320-6. PubMed ID: 4959332 [No Abstract] [Full Text] [Related]
2. [Soft tissue calcifications in collagenoses. (Contribution to the Thibierge-Weissenbach syndrome)]. Zielke A; Bolland G Z Rheumaforsch; 1965 Dec; 24(11):408-15. PubMed ID: 4958269 [No Abstract] [Full Text] [Related]
3. [Treatment of scleroderma]. Wüthrich B Schweiz Rundsch Med Prax; 1973 Sep; 62(38):1149-55. PubMed ID: 4148265 [No Abstract] [Full Text] [Related]
4. Failure of dimethyl sulfoxide in the treatment of scleroderma. Binnick SA; Shore SS; Corman A; Fleischmajer R Arch Dermatol; 1977 Oct; 113(10):1398-402. PubMed ID: 911168 [TBL] [Abstract][Full Text] [Related]
5. Medical Grand Rounds from the University of Alabama Medical Center. South Med J; 1967 Nov; 60(11):1202-12. PubMed ID: 6061189 [No Abstract] [Full Text] [Related]
6. Dimethyl sulfoxide in scleroderma. Ehrlich GE; Joseph R Pa Med; 1965 Dec; 68(12):51-3. PubMed ID: 5856390 [No Abstract] [Full Text] [Related]
7. A clinical trial with dimethyl sulfoxide in scleroderma. Tuffanelli DL Arch Dermatol; 1966 Jun; 93(6):724-5. PubMed ID: 5326715 [No Abstract] [Full Text] [Related]
8. Medical grand rounds from the University of Alabama Medical Center. Hardin JG; Coker AS; Blanton JH South Med J; 1969 Jul; 62(7):843-50. PubMed ID: 5306005 [No Abstract] [Full Text] [Related]
9. Medical grand rounds from the University of Alabama Medical Center. Dodson WH; Owen C; Hammack WJ South Med J; 1967 May; 60(5):517-25. PubMed ID: 6024621 [No Abstract] [Full Text] [Related]
10. Further observations on the effect of dimethyl sulfoxide in patients with generalized scleroderma. (Progressive systemic sclerosis). Scherbel AL; McCormack LJ; Layle JK Ann N Y Acad Sci; 1967 Mar; 141(1):613-29. PubMed ID: 5232269 [No Abstract] [Full Text] [Related]
11. [About some effects of dimethyl sulfoxide (DMSO) in percutaneous use]. Kappert A Schweiz Med Wochenschr; 1968 Nov; 98(46):1829-37. PubMed ID: 5705674 [No Abstract] [Full Text] [Related]
12. [Treatment results with dimethyl sulfoxide in circumscribed scleroderma]. Gärtner R; Flegel H Dermatol Wochenschr; 1968 Oct; 154(43):1015-22. PubMed ID: 5733089 [No Abstract] [Full Text] [Related]
13. Low molecular weight dextran in systemic sclerosis and Raynaud's phenomenon. Dodman B; Rowell NR Acta Derm Venereol; 1982; 62(5):440-2. PubMed ID: 6183899 [No Abstract] [Full Text] [Related]
14. [Dermatological experience with dimethyl sulfoxide (DMSO)]. Weitgasser H Z Haut Geschlechtskr; 1967 Sep; 42(18):749-54. PubMed ID: 5591425 [No Abstract] [Full Text] [Related]
15. Evaluation of dextran and DMSO to prevent necrosis in experimental pedicle flaps. McFarlane RM; Laird JJ; Lamon R; Finlayson AJ; Johnson R Plast Reconstr Surg; 1968 Jan; 41(1):64-70. PubMed ID: 4867245 [No Abstract] [Full Text] [Related]
16. [Trials of generalized scleroderma therapy with disodium versenate]. Machalski M; Wojtacha-Wencel B; Mazanek E Pol Tyg Lek; 1966 Mar; 21(13):467-70. PubMed ID: 4957497 [No Abstract] [Full Text] [Related]
17. Discussion paper: methodology and techniques in the evaluation of dimethyl sulfoxide for connective tissue disorders. Fleischmajer R Ann N Y Acad Sci; 1975 Jan; 243():393-4. PubMed ID: 1055555 [No Abstract] [Full Text] [Related]